Don't Write Off Baxter Just Yet

Core Viewpoint - Baxter International (BAX) was regarded as a strong player in the healthcare sector before the pandemic, with its stock trading at approximately 25 times the earnings per share at the end of 2019, indicating a significant premium valuation [1]. Group 1 - The stock performance of Baxter International prior to the pandemic was notable, reflecting investor confidence in its business model and growth potential [1].